NCT04930224View on ClinicalTrials.gov

Serum GPER-1 and Oxidant/Antioxidant Levels on Retinopathy in Diabetic Patients

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

January 31, 2020

Study Completion Date

April 25, 2020

Conditions
Diabetes MellitusDiabetic RetinopathyHormones
Interventions
DIAGNOSTIC_TEST

The effect of GPER-1 on the formation of diabetic retinopathy

Demonstrating the neuroprotective effect of GPER-1 in the formation of diabetic retinopathy and being a guide for new treatment models

Trial Locations (1)

46040

Abdullah Beyoğlu, Kahramanmaraş

All Listed Sponsors
lead

Kahramanmaras Sutcu Imam University

OTHER

NCT04930224 - Serum GPER-1 and Oxidant/Antioxidant Levels on Retinopathy in Diabetic Patients | Biotech Hunter | Biotech Hunter